Maximum quantity allowed is 999
CAS RN: 104239-97-6 | Product Number: O0515
3-Oxo-4-aza-5α-androst-1-ene-17β-carboxylic Acid
Purity: >98.0%(T)(HPLC)
- (4aR,4bS,6aS,7S,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic Acid
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
1G |
₹4,000.00
|
Contact Us | 3 |
|
5G |
₹17,640.00
|
3 | 30 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | O0515 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__1__9H__2__7NO__3 = 317.43 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
CAS RN | 104239-97-6 |
Reaxys Registry Number | 4265254 |
PubChem Substance ID | 468592533 |
MDL Number | MFCD08063794 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Neutralization titration) | min. 98.0 % |
Specific rotation [a]20/D | -3.0 to -6.0 deg(C=1, pyridine) |
Melting Point | 312 °C |
Specific Rotation | -3.8° (C=1,Pyridine) |
References
- A Scalable Synthesis of Dutasteride: A Selective 5α-Reductase Inhibitor
- Impurity profile study of dutasteride
- Mass spectral fragmentation reactions of a therapeutic 4-azasteroid and related compounds
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.